Hikal Limited is a leading global chemical company based in India. With over three decades of experience, the company specializes in the manufacturing and development of advanced chemicals, pharmaceutical intermediates, and crop protection products. Hikal operates across various industry segments, including agrochemicals, pharmaceuticals, and specialty chemicals. The company has a robust research and development (R&D) division that focuses on innovation and developing new technologies. This enables Hikal to offer a wide range of high-quality products and customized solutions to its customers. The R&D team works closely with clients to understand their specific requirements and develop tailored solutions to meet their needs.
- Hikal Limited reported Total Income for Q4 FY23 of ₹545.67 Crore up from ₹502.62 Crore year on year, a growth of 8.6%.
- Total Expenses for Q4 FY23 of ₹497.09 Crore up from ₹473.67 Crore year on year, a growth of 4.9%.
- Consolidated Net Profit of ₹36 Crore, up 73.8% from ₹20.71 Crore in the same quarter of the previous year.
- The Earnings per Share is ₹2.92, down from ₹1.68 in the same quarter of the previous year.